IDEAYA Biosciences, Inc. (IDYA) stock
IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/307% below fair value
$26.49−0.91 (-3.32%)
Close on Nov 18, 2026Market cap $2.56BP/E –Yield –
IDEAYA Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
IDEAYA Biosciences's market cap was $3.15B on Nov 11, 2026, against $3.12B a year earlier. Over the last 5 years it ranged from $369.53M to $3.86B, with a median of $2.10B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.15B | +4.0% |
| 2025 | Dec 31, 2025 | $3.03B | +36.6% |
| 2024 | Dec 31, 2024 | $2.22B | +6.4% |
| 2023 | Dec 29, 2023 | $2.09B | +138.7% |
| 2022 | Dec 30, 2022 | $873.80M | -3.9% |
| 2021 | Dec 31, 2021 | $909.27M | +123.4% |
| 2020 | Dec 31, 2020 | $406.93M | +166.9% |
| 2019 | Dec 31, 2019 | $152.46M | – |
See a number that looks wrong?